Monovisc Dosage – What is the Best Schedule?

Monovisc is a single-injection viscosupplement used to manage pain associated with knee osteoarthritis. Understanding the recommended Monovisc dosage matters because the treatment is administered as a single intra-articular injection rather than a series of weekly doses, so its dosing schedule differs from many other hyaluronic acid-based treatments.

Osteoarthritis affects an estimated 595 million people worldwide, representing 7.6% of the global population in 2020, with the prevalence of knee, hand, hip, and other forms of osteoarthritis projected to increase by 2050.[1] For patients who have not achieved sufficient relief with conservative treatments, Monovisc offers a non-surgical option designed to supplement the hyaluronic acid in synovial fluid and improve lubrication within the affected knee.

In this article, we’ll discuss the recommended dosing schedule for Monovisc, how the treatment is administered, factors clinicians consider when planning treatment and follow-up, and what patients can expect after receiving an injection.

Key Takeaways

• Monovisc is a treatment for knee osteoarthritis that requires a specific dosing schedule for optimal results.
• The standard dose and frequency of administration for Monovisc may vary based on individual patient factors.
• Adjusting the dosage of Monovisc based on patient-specific factors and clinical guidelines is essential for achieving the best outcomes.
• Medical professionals should monitor patient response, identify potential side effects, and collaborate with patients to optimize the treatment regimen.

About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and a range of medical and aesthetic products for your practice. We offer authentic products from leading brands at the lowest prices. Contact Doctor Medica today!

What is Monovisc?

Monovisc offers a solution for knee osteoarthritis pain with its high-molecular-weight hyaluronic acid packed in a single-use 5 mL syringe. It shines as an injectable option designed to mimic the body’s lubrication fluid in the knee.

This process aims to target and relieve pain in patients suffering from knee osteoarthritis. Since it’s usually given just once, there isn’t a daily dosing schedule to follow, making it an efficient treatment option.

Monovisc comes in a single-use 5 mL syringe, with 4 mL administered into each treated knee. If both knees require treatment, a separate syringe is used for each knee. This packaging is also relevant for clinics that buy Monovisc online, since inventory planning needs to account for one syringe per treated knee while ensuring the product comes from a reputable source and is stored appropriately.

The process provides relief by mimicking the body’s natural joint fluid, which can be less effective in people with osteoarthritis. With just a single injection of 4mL, patients can experience ease in knee pain. This treatment, involving high-molecular-weight hyaluronic acid in a single-use syringe, is explicitly created for intra-articular use, targeting the affected joint directly.

Recommended Monovisc Dosage Regimen

The recommended Monovisc dosage is a single 4 mL intra-articular injection containing 88 mg of hyaluronic acid, administered directly into the affected knee by a qualified healthcare professional. Unlike viscosupplements that require several appointments, Monovisc is designed as a single-injection treatment, eliminating the need for a weekly injection series.[2]

Treatment frequency is one of the clearest distinctions when comparing Monovisc vs Euflexxa. Monovisc is administered as one 4 mL injection, while Euflexxa is supplied in 2 mL prefilled syringes and is typically administered once weekly for three weeks. This difference may affect appointment scheduling, treatment convenience, and other practical considerations for both patients and clinics.

Because Monovisc follows a fixed single-dose regimen, clinicians do not routinely adjust the amount administered according to symptom severity. Instead, treatment decisions should be based on whether the patient is an appropriate candidate, their response to previous conservative therapies, and their clinical condition.

Factors Influencing the Recommended Dosage

Finding the correct dosage of Monovisc is essential for effective knee osteoarthritis treatment. Here are key factors to consider:

• Symptom Severity: Patients with severe symptoms may need the complete 4mL injection for maximum relief.
• Health and Medical History: Doctors might adjust the dose based on other health conditions to ensure safety and effectiveness.
• Standard Dosage: Typically, Monovisc is administered as a single 4mL dose per knee, simplifying treatment for bilateral osteoarthritis.
• Duration of Effectiveness: Monovisc can last up to six months, influencing the timing of follow-up doses.
• Patient Monitoring: Regular check-ups at baseline and weeks 2, 4, and 26 help fine-tune future dosages.
• Onset of Action: Most patients start feeling relief within 24-48 hours, with significant effects by two weeks. This helps them set realistic expectations and schedule follow-ups.

Adjusting the Dosage

Monovisc dosage needs to be carefully adjusted based on the patient. Each person’s health, history, and reaction to past treatments play a critical role.

• Severity of Knee Osteoarthritis Symptoms: Patients with more severe symptoms might require closer monitoring after the Monovisc injection to track progress and adjust care as needed.
• Overall Health and Medical History: A patient’s physical condition, allergies, or treatment reactions can influence how well they respond to Monovisc.
• Response to Previous Treatments for Knee Osteoarthritis: If other methods like physical therapy or different injections didn’t work well, Monovisc could be a new option, but it requires watching how the patient reacts over time.

Clinical Guidelines and Expert Recommendations

Doctors have found that Monovisc, a high-molecular-weight hyaluronic acid, relieves knee osteoarthritis pain. This intra-articular injection is done as a single 4mL dose directly into the knee. One syringe per knee works best for patients with pain in both knees. The treatment shows results quickly, typically starting two weeks after the injection and lasting up to six months.

Experts have also found that patients experience meaningful improvements in pain and mobility with minimal side effects, making it a preferred choice for those seeking non-surgical management of osteoarthritis.[3]

Best Practices for Adjusting the Dosage

Monovisc is designed as a single-dose injection, and its administration does not typically require dosage adjustment. However, there are best practices to ensure its optimal efficacy and safety:

• Patient Selection: Ideal candidates for Monovisc are those with mild to moderate knee osteoarthritis who have not responded adequately to other conservative treatments such as physical therapy or oral medications. Assess the patient’s overall health and joint condition before recommending Monovisc.
• Injection Technique: Proper administration technique is critical. Perform the injection using sterile technique to avoid infection. Administer it directly into the knee joint, and ensure precise placement within the joint space for optimal results.
• Monitoring and Follow-Up: Post-injection, patients should be monitored for any adverse reactions, such as localized pain or swelling. While serious side effects are rare, it is important to provide patients with guidelines on what to expect and when to seek medical attention.
• Repeat Injections: Although Monovisc is designed for single-dose administration, some patients may require repeat injections based on their clinical response and symptom recurrence. Clinical guidelines suggest evaluating the patient’s symptoms every six months to determine the need for another injection.
• Combination with Other Therapies: Combining Monovisc with other treatments, such as physical therapy, weight management, and strengthening exercises, can enhance overall outcomes. Physicians should create a comprehensive treatment plan tailored to the patient’s needs.

Practical Tips for Medical Professionals

Monitoring patient response is crucial after administering Monovisc for osteoarthritis knee pain relief. Patients generally see full effects within 24–48 hours, but ongoing observation helps ensure the best outcomes.

• Check the onset of action around two weeks post-injection, since Monovisc has a proven onset at this time for alleviating osteoarthritis pain.
• Follow up with patients for 26 weeks, as typical monitoring includes visits at screening, baseline, and weeks 2, 4, and 26.
• Observe for immediate adverse reactions in the first few days after injection. It’s critical to catch and manage these early.
• Ask patients about improvements in knee function or pain reduction at each follow-up visit to assess effectiveness.
• Document any side effects patients report to identify potential patterns or needs for dosage adjustments.
• Compare patient-reported outcomes with baseline knee functionality to gauge overall treatment. 

Doctors look at how well knee pain goes down and if patients can move better. They see Monovisc working when pain drops in 2 weeks and lasts up to 6 months. A promising sign is needing less medicine for pain or feeling better moving around.

Side effects can show up after the injection is given into the knee. Since every patient’s body reacts differently, tracking is critical for six months—when Monovisc shows its pain relief powers. Monovisc injections may initially cause discomfort in some patients. This process usually happens within 24–48 hours post-injection and calms down quickly. Itching, swelling, or redness around the knee might also occur.

Conclusion

Finding the perfect Monovisc dosage schedule means looking closely at each patient’s needs. A single 4mL shot might be all it takes for one knee. If both knees hurt, they’ll need a dose each.

Patients won’t have to return for daily shots since one injection lasts up to six months. Listening and adjusting is critical—what works well now may need tweaking later. This personalized approach helps keep pain in check and mobility high.

FAQs

1. What is the right amount of Monovisc I should take?

Usually, one shot is enough for relief.

2. How often do I need to get a Monovisc shot?

You might only need it once, but check with your doctor if symptoms return.

3. Can I take Monovisc shots at home?

Only a qualified healthcare professional can give Monovisc shots. It’s usually performed in an office or clinic setting.

4. Will I need more shots after my first Monovisc injection?

Maybe not, but your doctor will tell you if you do.

5. How long does it take for Monovisc to start working?

It can kick in quickly, sometimes within a few days.

Citations

[1] GBD 2021 Osteoarthritis Collaborators. “Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.” The Lancet. Rheumatology vol. 5,9 e508-e522. 21 Aug. 2023, doi:10.1016/S2665-9913(23)00163-7

[2] McCormack, Robert et al. “Comparison of the 3 Different Injection Techniques Used in a Randomized Controlled Study Evaluating a Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) for Osteoarthritis of the Knee: A Subgroup Analysis.” Clinical medicine insights. Arthritis and musculoskeletal disorders vol. 10 1179544117725026. 14 Aug. 2017, doi:10.1177/1179544117725026

[3] Peck, Jacquelin et al. “A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee.” Orthopedic reviews vol. 13,2 25549. 10 Jul. 2021, doi:10.52965/001c.25549